IPHA | Innate Pharma S.A.
Quick infos Headquarters: Marseille, France Trade prices Volume: Market Cap: 255.07M Prev closed: 5.83 Open: 5.61 High: 6.5 Low: 5.54 52 week low: 3.02 52 week high: 8.9 Dividends: No Dividends Next ER: March 23, 2023 Before Market Opens
Earnings History Date EPS / Forecast Revenue / Forecast May 10, 2023 March 23, 2023 - / -0.32- / 14.95MNovember 14, 2022 - / - - / - September 15, 2022 0.08 / -0.2641.27M / 21.38MBeat! May 10, 2022 - / - 2.6M / -Beat! view more
Historical Data Date Price Open High Low Vol Change ER Mar 17, 2022 3.06 3.07 3.12
3.00
236.13K 2.96% Mar 16, 2022 2.97 3.04 3.09
2.97
174.87K 0.81% Mar 15, 2022 2.95 3.00 3.00
2.89
225.37K -2.06% Mar 14, 2022 3.01 2.94 3.04
2.94
191.13K 2.45% Mar 11, 2022 2.94 2.99 3.04
2.92
271.97K -1.14% Mar 10, 2022 2.97 2.80 3.20
2.79
581.64K 7.36% Mar 9, 2022 2.77 2.74 2.80
2.60
490.64K 3.44% Mar 8, 2022 2.68 2.54 2.71
2.50
473.07K 4.61% Mar 7, 2022 2.56 2.52 2.65
2.44
666.59K -6.71% Mar 4, 2022 2.74 2.90 2.93
2.72
337.58K -6.03% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:1999 Employees:244 News
What Is Happening With Innate Pharma Stock On Friday? finance.yahoo.com Jan 31, 2023 10:10 am
Monalizumab Data from COAST Trial Presented at ESMO Congress 2021 finance.yahoo.com Jan 31, 2023 7:45 am
Innate Pharma: Monalizumab Combined With Cetuximab and Durvalumab Demonstrates Anti-Tumor Activity in First-Line Recurrent or Metastatic Head and Neck Cancer at ESMO Immuno-Oncology 2021 Congress finance.yahoo.com Jan 31, 2023 5:00 am
Innate Pharma Announces Conference Call and Webcast for Q1 2022 Business Update finance.yahoo.com Jan 31, 2023 1:00 am
Innate Pharma Provides Update on AstraZeneca-Sponsored INTERLINK-1 Phase 3 Study finance.yahoo.com Jan 31, 2023 1:00 am Innate, Sanofi licensing deal gets US antitrust clearance seekingalpha.com Jan 25, 2023 5:26 pm AMRS, TTM and OMER among premarket gainers seekingalpha.com Dec 27, 2022 9:24 pm Sanofi and Innate Pharma join hands for NK cell therapeutics in oncology seekingalpha.com Dec 19, 2022 7:55 pm
Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology finance.yahoo.com Dec 19, 2022 1:00 am
Innate Pharma to present adenosine franchise, IPH5201 and IPH5301 at ESMO IO 2022 finance.yahoo.com Dec 1, 2022 1:00 am
Innate Pharma to Participate in Upcoming Investor Conferences finance.yahoo.com Nov 2, 2022 2:00 am
Innate Pharma Presents Data From Ongoing Phase 2 TELLOMAK Trial Demonstrating Clinical Activity of Lacutamab in Advanced Mycosis Fungoides finance.yahoo.com Sep 23, 2022 1:00 am Innate Pharma GAAP EPS of €0.08, revenue of €45.59M seekingalpha.com Sep 15, 2022 2:34 pm Hot Stocks: BA jumps on Dreamliner news, HSBC gains on earnings, PSO also rises 10%, while IPHA sinks seekingalpha.com Aug 1, 2022 8:22 pm Innate stock slumps 16% as AstraZeneca pulls plug on monalizumab in head/neck cancer after trial failure seekingalpha.com Aug 1, 2022 6:16 pm
Innate Pharma Reports First Half 2022 Financial Results and Business Update finance.yahoo.com Jan 31, 2023 1:00 am
Number of Shares and Voting Rights of Innate Pharma as of May 1, 2022 finance.yahoo.com Jan 31, 2023 12:55 am
Innate Pharma Announces HSR Clearance Regarding Expansion of Its Collaboration With Sanofi on NK Cell Engagers finance.yahoo.com Jan 25, 2023 1:00 am
Innate Pharma Presents Data From Ongoing Phase 2 TELLOMAK Trial Demonstrating Clinical Activity of Lacutamab in Advanced Sézary Syndrome at ASH 2022 finance.yahoo.com Dec 10, 2022 10:00 am Innate Pharma reports 9M results seekingalpha.com Nov 14, 2022 2:52 pm This company doesn't provide a dividend.
Talk about Innate Pharma S.A. below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
investors.innate-pharma.com If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!
